Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Certara (CERT)
NASDAQ:CERT
Certara (CERT) Stock Price & Analysis
185 Followers
CERT Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$11.81 - $19.87
Previous Close$13.66
Volume7.28K
Average Volume (3M)586.13K
Market Cap
$2.20B
Enterprise Value$2.26B
Total Cash (Recent Filing)$234.95M
Total Debt (Recent Filing)$298.19M
Price to Earnings (P/E)―
Beta1.57
Next Earnings
Aug 06, 2024EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.39
Shares Outstanding160,841,451
10 Day Avg. Volume916,209
30 Day Avg. Volume586,132
Standard Deviation0.16
R-Squared0.23
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)-14.02
Price to Sales (P/S)6.19
Price to Cash Flow (P/CF)23.50
P/FCF Ratio22.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.38
Enterprise Value/Gross Profit10.60
Enterprise Value/Ebitda711.92
Forecast
1Y Price Target
$19.25Price Target Upside40.51% Upside
Rating ConsensusHold
Number of Analyst Covering5
Certara News
Bulls Say, Bears Say
Bulls Say
Financial Performance1Q24 total revenue increased 7% YoY, with software up 8%.
Industry ImpactOver 90% of FDA approvals over the past decade have originated from Certara software and services customers.
Product LaunchThe launch of the Certara Cloud platform could be accretive on a near-term basis and provides both growth opportunities and cost savings potential longer term.
Bears Say
BookingsTotal bookings declined 6% YoY, with services down 11%.
Financial PerformanceEBITDA margins came in below the bottom end of the full year guidance range, driven by one-off M&A integrations and elevated OpEx related to sales force hirings and R&D investments in the regulatory business.
Market ActivityThe report expresses caution due to decelerating clinical trial initiations and modest biopharma capital markets activity, impacting near-term organic growth expectations.
---
Ownership Overview
4.16% Insiders
28.33% Mutual Funds
15.59% Other Institutional Investors
51.93% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CERT FAQ
What was Certara’s price range in the past 12 months?
Certara lowest stock price was $11.81 and its highest was $19.87 in the past 12 months.
What is Certara’s market cap?
Currently, no data Available
When is Certara’s upcoming earnings report date?
Certara’s upcoming earnings report date is Aug 06, 2024 which is in 34 days.
How were Certara’s earnings last quarter?
Certara released its earnings results on May 07, 2024. The company reported $0.1 earnings per share for the quarter, missing the consensus estimate of $0.103 by -$0.003.
Is Certara overvalued?
According to Wall Street analysts Certara’s price is currently Undervalued.
Does Certara pay dividends?
Certara does not currently pay dividends.
What is Certara’s EPS estimate?
Certara’s EPS estimate is $0.1.
How many shares outstanding does Certara have?
Certara has 160,841,450 shares outstanding.
What happened to Certara’s price movement after its last earnings report?
Certara reported an EPS of $0.1 in its last earnings report, missing expectations of $0.103. Following the earnings report the stock price went down -7.418%.
Which hedge fund is a major shareholder of Certara?
Among the largest hedge funds holding Certara’s share is Gotham Asset Management LLC. It holds Certara’s shares valued at 4M.
---
Certara Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$19.25 (40.51% Upside)
$19.25 (40.51% Upside)
Blogger Sentiment
Bullish
CERT Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 24.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 2.7%
Last 30 Days ▼ 5.4%
Last 30 Days ▼ 5.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.98%
12-Months-Change
Fundamentals
Return on Equity
-5.74%
Trailing 12-Months
Asset Growth
-1.56%
Trailing 12-Months
Company Description
Certara
Certara Inc accelerate medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides proven modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trial, accelerate regulatory approval and increase patient access to medicines.
---
CERT Company Deck
---
CERT Earnings Call
Q1 2024
0:00 / 0:00
---
CERT Stock 12 Month Forecast
Average Price Target
$19.25
▲(40.51% Upside)
Technical Analysis
Best Analysts Covering CERT
1 Year
1 Year Success Rate
1/5 ratings generated profit
1 Year Average Return
-11.40%
reiterated a buy rating 10 months ago
Copying Gaurav Goparaju's trades and holding each position for 1 Year would result in 20.00% of your transactions generating a profit, with an average return of -11.40% per trade.
---